Short answer
Cigna (CI) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for the three months ended June 30, 2026.
Cigna 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for the three months ended June 30, 2026
- Press release furnished as Exhibit 99.1, containing the detailed financial results
- Information furnished under Item 2.02, not deemed filed under Exchange Act Section 18
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue rose 7% to $71.7B; adjusted operating income increased 6% to $2.1B, signaling solid execution
- Adjusted EPS reached $7.78 versus $7.20, while GAAP EPS increased to $6.29 from $5.71
- 2026 adjusted EPS outlook raised $0.10 to at least $30.45, supporting improved earnings visibility
- Pharmacy Benefit Services income fell 27% despite 8% revenue growth, creating pressure from client-focused contract initiatives
- Cigna Healthcare income rose 17% to $1.3B, offsetting Evernorth weakness; medical care ratio increased to 84.5% from 83.2%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cigna 8-K filings
Get the next CI 8-K as it lands
Follow CI for push alerts, or ask the research agent what this filing means.